Stock Analysis
Glaukos Corporation (GKOS) Stock Analysis
Glaukos Corporation (GKOS) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Glaukos Corporation (GKOS) currently has an AIQ Score of 65/100, indicating a bullish setup. Momentum is the strongest factor at 90/100. Value is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
GKOS at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $233.08 |
| AIQ Score | 65/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $14.52B |
| P/E Ratio (TTM) | -82.74 |
| Forward P/E | — |
| EPS (Q3 FY2026) | $0.03 |
| Revenue (Q3 FY2026) | $211.03M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.06 |
| Volume | 1.13M |
| 52-week range | $87.32-$255.19 |
| RSI 14 | 68.68 |
| 50-Day SMA | $184.62 |
| 200-Day SMA | $147.26 |
| Analyst Price Target | $234.00 |
| Next Earnings | Feb 16, 2027 |
GKOSGlaukos Corporation
Healthcare / Medical - Devices
Leader
Strong Relative Position
Latest quote
- Momentum90
- Value30
- Quality64
- Risk resilience57
- Sentiment—
GKOS Stock Analysis Summary
Glaukos Corporation (GKOS) currently has an AIQ Score of 65/100, indicating a bullish setup. Momentum is the strongest factor at 90/100. Value is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, GKOS has AIQ Score of 65/100 with Momentum base of 90/100 and fading Value at 30/100. Wait for component alignment before adding exposure.
Momentum (90/100) leads while Value (30/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -4.18% stock move · GKOS classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is GKOS Bullish or Bearish Right Now?
GKOS currently has a bullish overall setup. Momentum is the strongest factor at 90/100, while Value is weakest at 30/100. The current evidence suggests a constructive setup.
- - Momentum is constructive at 90/100.
- - Price is +33.10% above its 50-day SMA.
- - Analyst target implies +0.39% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 5).
- - Value is the current constraint at 30/100.
Current Consensus
GKOS's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 6 neutral, and 5 sell votes. GKOS's 14-day RSI is 68.68, which places the stock in a constructive momentum range. GKOS's beta is 1.06, indicating market sensitivity broadly in line with the market.
What Changed in GKOS?
The largest recent change in GKOS is Momentum moving down by 2.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the GKOS Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
GKOS Decision Framework
Public evidence layers, setup checks, and risk context for Glaukos Corporation.
Glaukos Corporation (GKOS) Stock Analysis
Glaukos Corporation has an AIQ Score of 65/100 in a Bullish regime. Momentum is strongest at 90/100. Beta is 1.06, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | GKOS is in a Bullish AIQ regime with score 65/100. |
| Signal Conflict | The primary conflict is that momentum leads at 90/100 while value lags at 30/100. |
| Factor Evidence | Momentum 90/100 · Value 30/100 · Quality 64/100 · Risk 57/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 90/100.
Momentum is 90/100 and RSI (14) is 68.7.
GKOS is in a Bullish regime at 65/100.
Risk factor is 57/100 with beta 1.06 and annual volatility 61.36%.
Current conflict: momentum leads at 90/100 while value lags at 30/100.
GKOS Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
GKOS Fundamentals
GKOS valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
GKOS Technical Analysis
GKOS technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
GKOS Stock Catalysts
Track GKOS earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
GKOS Dividend Analysis
GKOS dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
GKOS Financial Data
GKOS revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
GKOS Risk Analysis
GKOS volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
GKOS Stock News
GKOS stock news, market tone, recent headlines, and catalyst context.
GKOS vs Medical - Devices Peers
Current peer cohort: GKOS · HAE · IRTC · ITGR · LIVN. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| GKOS Current stock | 65/100 | 30/100 | 90/100 | 57/100 | 1.83 | 61.36% | Current |
| HAE Haemonetics Corporation | 77/100 | 60/100 | 91/100 | 67/100 | 1.35 | 41.04% | GKOS vs HAE |
| IRTC iRhythm Technologies, Inc. | 44/100 | 43/100 | 34/100 | 44/100 | -0.91 | 54.02% | GKOS vs IRTC |
| ITGR Integer Holdings Corporation | — | — | 85/100 | 80/100 | 2.02 | 31.24% | GKOS vs ITGR |
| LIVN LivaNova PLC | 71/100 | 60/100 | 83/100 | 71/100 | 1.38 | 39.16% | GKOS vs LIVN |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for GKOS: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching GKOS
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for GKOS
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
GKOS Stock FAQ
What is GKOS stock price today?
Glaukos Corporation's current stock price is $233.08. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is GKOS bullish or bearish right now?
GKOS's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is GKOS's market cap?
GKOS's market cap is $14.52B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is GKOS's current P/E ratio?
GKOS's current P/E ratio is -82.74 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is GKOS's RSI?
GKOS's 14-day RSI is 68.68 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is GKOS above its 50-day and 200-day moving averages?
GKOS is 33.10% from its 50-day SMA and 66.86% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is GKOS's next earnings date?
GKOS's next earnings date is currently listed as Feb 16, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does GKOS pay a dividend?
GKOS's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.